United States· US:65174-200_9799f139-0c16-4cf0-8a7d-e9668ec3f146

Drax Exametazime

A medicinal product containing technetium tc-99m exametazime, registered in United States by Jubilant DraxImage Inc., dba Jubilant Radiopharma.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDrax ExametazimeATC—REGISTER NO.US:65174-200_9799f139…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TECHNETIUM TC-99M EXAMETAZIME
Manufacturer
Jubilant DraxImage Inc., dba Jubilant Radiopharma
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6517420005
    5 VIAL in 1 CARTON (65174-200-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (65174-200-01)
  • ndc11
    65174-200-05

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Technetium tc-99m exametazime in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All technetium tc-99m exametazime products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Stabilised Ceretec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2c49b37-bebd-43b3-904c-9027764a5caf
GET /v1/drugs/c2c49b37-bebd-43b3-904c-9027764a5caf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": ".5",
  "substance": "TECHNETIUM TC-99M EXAMETAZIME",
  "productndc": "65174-200",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA208870",
  "marketing_category": "NDA"
}

See everything about technetium tc-99m exametazime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.